Status:
COMPLETED
A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease
Lead Sponsor:
Centocor, Inc.
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
A study of infliximab in patients with Fistulizing Crohn's Disease
Detailed Description
This is a medical research study for patients with Crohn's disease who have one or more draining enterocutaneous fistula (fistula from the bowel to the skin). Fistulas are a common complication of Cro...
Eligibility Criteria
Inclusion
- Single or multiple draining fistulas
- Crohn's disease of at least 3 months' duration,
Exclusion
- Crohn's disease complications for which surgery might be indicated
- Positive stool culture
Key Trial Info
Start Date :
June 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT00207766
Start Date
June 1 2000
End Date
August 1 2006
Last Update
April 27 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.